IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 384
Titolo Data di pubblicazione Autore(i) File
Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma 1-gen-2002 Boccadoro, M; Palumbo, A; Bringhen, S; Merletti, F; Ciccone, G; Richiardi, L; Rus C, ; Bertola, A; Giaccone, L; Omedè, P; Musto, P
Inefficacy of clarithromycin in advanced multiple myeloma: a definitive report 1-gen-2002 Musto, P; Falcone, A; Sanpaolo, G; Bodenizza, C; Carotenuto, M; Carella, Am
Combined therapy with amifostine plus erythropoietin for the treatment of myelodysplastic syndromes 1-gen-2002 Grossi, A; Musto, P; Santini, V; Balestri, F; Fabbri, A; Falcone, A; Sanpaolo, G
Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes 1-gen-2002 Musto, P; Falcone, A; Sanpaolo, G; Bisceglia, M; Matera, R; Carella, Am
Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? Results of a long-term study 1-gen-2002 Cascavilla, N; Musto, P; Melillo, L; Bodenizza, C; Dell'Olio, M; Nobile, M; Minervini, Mm; Perla, G; D'Arena, G; Carella, Am
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma 1-gen-2002 Tosi, P; Zamagni, E; Cellini, C; Ronconi, S; Patriarca, F; Ballerini, F; Musto, P; DI RAIMONDO, F; Ledda, A; Lauria, F; Masini, L; Gobbi, M; Vacca, Angelo; Ria, Roberto; Cangini, D; Tura, S; Baccarani, M; Cavo, M.
Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial 1-gen-2003 Musto, P; Falcone, A; Sanpaolo, G; Bodenizza, C; Cascavilla, N; Melillo, L; Scalzulli, Pr; Dell'Olio, M; La Sala, A; Mantuano, S; Nobile, M; Carella, Am
Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes 1-gen-2003 Musto, P; Falcone, A; Sanpaolo, G; Bodenizza, C; La Sala, A; Perla, G; Carella, Am
Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association 1-gen-2003 Musto, P
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study 1-gen-2003 Mele, A; Pulsoni, A; Bianco, E; Musto, P; Szklo, A; Sanpaolo, Mg; Iannitto, E; De Renzo, A; Martino, B; Liso, V; Andrizzi, C; Pusterla, S; Dore, F; Maresca, M; Rapicetta M, ; Marcucci, F; Mandelli, F; Franceschi, S
Pamidronate for early-stage, untreated myeloma 1-gen-2003 Musto, P; Falcone, A; Sanpaolo, G; Bodenizza, C; Carella, Am
Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives 1-gen-2004 Musto, P
Imatinib-mesylate for all patients with hypereosinophilic syndrome? 1-gen-2004 Musto, P; Perla, G; Minervini, Mm; Carella, Am; Coco, Fl; Catalano, G
Tandem bone marrow transplantation in multiple myeloma 1-gen-2004 Musto, P
Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis 1-gen-2004 Musto, P; Falcone, A; Sanpaolo, G; Bodenizza, C; Perla, G; Minervini, Mm; Cascavilla, N; Dell'Olio, M; La Sala, A; Mantuano, S; Melillo, L; Nobile, M; Scalzulli PR, ; Bisceglia, M; Carella, Am
Possible multiple myeloma dedifferentiation following thalidomide therapy: a report of four cases 1-gen-2004 Balleari, E; Ghio, R; Falcone, A; Musto, P
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study 1-gen-2004 Bianco, E; Marcucci, F; Mele, A; Musto, P; Cotichini, R; Sanpaolo, Mg; Iannitto, E; De Renzo, A; Martino, B; Specchia, G; Montanaro, M; Barbui, Am; Nieddu, R; Pagano, L; Rapicetta, M; Franceschi, S; Mandelli, F; Pulsoni, A
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial 1-gen-2004 Palumbo, A; Bringhen, S; Petrucci, Mt; Musto, P; Rossini, F; Nunzi, M; Lauta, Vm; Bergonzi, C; Barbui, A; Caravita, T; Capaldi, A; Pregno, P; Guglielmelli, T; Grasso, M; Callea, V; Bertola, A; Cavallo, F; Falco, P; Rus, C; Massaia, M; Mandelli, F; Carella AM, ; Pogliani, E; Liberati, Am; Dammacco, F; Ciccone, G; Boccadoro, M
Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2)) 1-gen-2004 Palumbo, A; Bringhen, S; Bertola, A; Cavallo, F; Falco, P; Massaia, M; Bruno, B; Rus, C; Barbui, A; Caravita, T; Musto, P; Pescosta, N; Rossini, F; Vignetti, M; Boccadoro, M
Inefficacy of imatinib-mesylate in sporadic, aggressive systemic mastocytosis 1-gen-2004 Musto, P; Falcone, A; Sanpaolo, G; Bodenizza, C; Carella, Am
Mostrati risultati da 1 a 20 di 384
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile